🇺🇸 FDA
Patent

US 8703727

Nanotechnology formulation of poorly soluble compounds

granted A61KA61K31/133A61K31/167

Quick answer

US patent 8703727 (Nanotechnology formulation of poorly soluble compounds) held by Aphios Corporation expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aphios Corporation
Grant date
Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/133, A61K31/167, A61K31/352, A61K31/395